Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Southern African mining sector to receive $140m for anti-TB initiatives

The World Bank is set to release the first tranche of its $120-million contribution to the fight against tuberculosis (TB) in Southern Africa’s mining sector during the first quarter of this year.

Published
20 January 2016
From
Mining Weekly
European Union Joint Action on HIV and Co - infection Prevention and Harm Reduction launched

On 14-15 January 2016 in Vilnius, Lithuania, the European Union Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) held its first Partnership Forum to kick off activities. HA-REACT addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID).

Published
18 January 2016
From
Manual Items
NICE publishes new guideline to better tackle tuberculosis

NICE – the National Institute for Health and Care Excellence of England – published guidance on how to better treat and prevent tuberculosis. England has more TB cases than any other country in Western Europe.

Published
15 January 2016
From
NICE press release
MDR-TB treatment: Six drugs better than five

A regimen containing six drugs was more likely to cure multi-drug resistant tuberculosis (MDR-TB) than a regimen containing five drugs, a nine-country observational study has

Published
13 January 2016
By
Keith Alcorn
USAID announces new partnerships to combat MDR-TB

At last week’s launch of the National Action Plan for Combating Multidrug-Resistant Tuberculosis, the U.S. Agency for International Development announced expanded partnerships with Janssen, the maker of bedaquiline, the first tuberculosis drug to be produced since the 1950s, and Cepheid, maker of the GeneXpert rapid diagnostic test for drug-resistant tuberculosis.

Published
13 January 2016
From
Science Speaks
TAG’s Response to the U.S. Action Plan for Combating Multidrug Resistant Tuberculosis

Treatment Action Group (TAG) welcomes the release of the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis. Strengthening the domestic and global and research efforts to address multidrug-resistant tuberculosis (MDR-TB) are critical to ending the suffering this preventable, curable disease needlessly causes. However, the targets set forth in this plan are not ambitious enough to effectively stop the spread of MDR-TB.

Published
11 January 2016
From
Treatment Action Group
LAM point-of-care TB testing reduces mortality in people with HIV/TB co-infection in hospital

All-cause 8-week mortality is reduced by rapid point-of-care urine-based testing for tuberculosis (TB), using a test for detection of mycobacterial lipoarabinomannan (LAM) to guide rapid treatment initiation in

Published
08 January 2016
By
Lesley Odendal
Xpert MTB/RIF testing has reduced MDR-TB treatment delays in South Africa

Although the introduction of the Xpert MTB/RIF test for TB and drug-resistant TB has improved the time from clinic presentation to second-line treatment in South Africa since

Published
07 January 2016
By
Lesley Odendal
One in eight children with confirmed TB have drug-resistant TB in Cape Town

One in eight children with confirmed TB have drug-resistant TB in Cape Town, South Africa, according to a surveillance study of childhood TB drug-resistance, presented by Professor

Published
05 January 2016
By
Lesley Odendal
Community care workers boost TB case finding among hard-to-reach adults

Community care worker active case finding is an effective tool for increasing TB case detection, according to two studies presented at the 46th Union World Conference on

Published
23 December 2015
By
Lesley Odendal

Filter by country